je.st
news
Johnson & Johnson posts mixed 3Q results, authorizes buyback
2015-10-13 16:02:19| Biotech - Topix.net
Health care giant Johnson & Johnson posted a 29 percent drop in third-quarter earnings, hammered by plunging sales of its hepatitis C medicine and unfavorable currency exchange rates that reduced the value of overseas sales. Its year-ago results had also included a big gain from selling a diagnostics business.
Tags: results
posts
johnson
mixed
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||